A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia

Hallberg, 1966, Menstrual blood loss—a population study, Acta Obstet Gynecol Scand, 45, 320, 10.3109/00016346609158455

Rybo, 1966, Clinical and experimental studies on menstrual blood loss, Acta Obstet Gynecol Scand, 45, 1, 10.3109/00016346609158476

Cohen, 1980, Anemia and menstrual blood loss, Obstet Gynecol Surv, 35, 597

Van Eijkeren, 1989, Menorrhagia: a review, Obstet Gynecol Surv, 44, 421, 10.1097/00006254-198906000-00003

Rees, 1989, Heavy, painful periods, Clin Obstet Gynecol, 3, 341

Nilsson, 1971, Treatment of menorrhagia, Am J Obstet Gynecol, 110, 713, 10.1016/0002-9378(71)90259-6

Anderson, 1976, Reduction of menstrual blood loss by prostaglandin synthetase inhibitors, Lancet, 1, 774, 10.1016/S0140-6736(76)91612-3

Bergqvist, 1983, Treatment of menorrhagia with intrauterine release of progesterone, Br J Obstet Gynaecol, 90, 255, 10.1111/j.1471-0528.1983.tb08620.x

Andersch, 1988, An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia, Acta Obstet Gynaecol Scand, 67, 645, 10.3109/00016348809004279

Andersson, 1990, Levonorgestrel-releasing intrauterine device in treatment of menorrhagia, Br J Obstet Gynaecol, 97, 690, 10.1111/j.1471-0528.1990.tb16240.x

Hallberg, 1964, Determination of menstrual blood loss, Scand J Clin Lab Invest, 16, 244, 10.3109/00365516409060511

Newton, 1977, A rapid method for measuring menstrual blood loss using automatic extraction, Contraception, 16, 269, 10.1016/0010-7824(77)90026-9

Rybo, 1966, Plasminogen activators in the endometrium. II. Clinical aspects, Acta Obstet Gynecol Scand, 45, 429, 10.3109/00016346609158462

Smith, 1981, A role of prostacyclin (PGI2) in excessive menstrual bleeding, Lancet, 1, 522, 10.1016/S0140-6736(81)92862-2

Rees, 1984, Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea, Br J Obstet Gynaecol, 91, 673, 10.1111/j.1471-0528.1984.tb04829.x

Rybo, 1981, Naproxen in menorrhagia, Lancet, 1, 608, 10.1016/S0140-6736(81)92051-1

Ylikorkala, 1983, Comparison between antifibri-nolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intra- uterine contraceptive devices, Br J Obstet Gynaecol, 90, 78, 10.1111/j.1471-0528.1983.tb06751.x

Hagenfeldt, 1977, Biochemical and morphological changes in the human endometrium induced by the Progestasert device, Contraception, 16, 183, 10.1016/0010-7824(77)90086-5

Nilsson, 1978, Endometrial morphology of women using a d-norgestrel-releasing intrauterine device, Fertil Steril, 29, 397, 10.1016/S0015-0282(16)43212-7

Luukkainen, 1987, Effective contraception with the levonorgestrel-releasing intrauterine device. 12 months report of a European multicentre study, Contraception, 36, 169, 10.1016/0010-7824(87)90012-6

Weström, 1980, Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries, Am J Obstet Gynecol, 138, 880, 10.1016/0002-9378(80)91077-7

Dicker, 1982, Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States, Am J Obstet Gynecol, 144, 841, 10.1016/0002-9378(82)90362-3

Macdonald, 1990, Modern treatment of menorrhagia, Br J Obstet Gynaecol, 97, 3, 10.1111/j.1471-0528.1990.tb01709.x